Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

Phase: N/A Priority: Normal
NCT ID: NCT03293524 Org: User:
Start: 03/12/18 End: 06/30/24 Due: 06/30/25

RESCUE and REVERSE Long-term Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT03406104 Org: User:
Start: 01/09/18 End: 07/04/22 Due: 07/04/23

Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)

Phase: N/A Priority: Normal
NCT ID: NCT02652780 Org: User:
Start: 01/31/16 End: 12/31/18 Due: 12/31/19

EAP_GS010_single Patient

Phase: N/A Priority: Normal
NCT ID: NCT03672968 Org: User:
Start: - End: - Due: -

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT03326336 Org: User:
Start: 09/26/18 End: 12/31/25 Due: 12/31/26

Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02064569 Org: User:
Start: 02/13/14 End: 06/25/20 Due: 06/25/21

REALITY LHON Registry

Phase: N/A Priority: Normal
NCT ID: NCT03295071 Org: User:
Start: 01/03/18 End: 07/01/20 Due: 07/01/21

Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02652767 Org: User:
Start: 02/23/16 End: 07/04/19 Due: 07/04/20